Efficacy of adjuvant chemotherapy with carboplatin for early triple negative breast cancer: a single center experience

BACKGROUND: Anthracycline- and taxane-based adjuvant chemotherapies are the most frequently used systemic treatments for women with triple negative breast cancer (TNBC). Adding platinum derivatives in the neo-adjuvant setting has been shown to not only improve the pCR rates, but also the 3 year DFS...

Descripción completa

Detalles Bibliográficos
Autores principales: Vetter, Marcus, Fokas, Spyridon, Biskup, Ewelina, Schmid, Thomas, Schwab, Fabienne, Schoetzau, Andreas, Güth, Uwe, Rochlitz, Christoph, Zanetti-Dällenbach, Rosanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650451/
https://www.ncbi.nlm.nih.gov/pubmed/29088896
http://dx.doi.org/10.18632/oncotarget.18118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650451/
https://www.ncbi.nlm.nih.gov/pubmed/29088896
http://dx.doi.org/10.18632/oncotarget.18118

Ejemplares similares